Literature DB >> 18195038

Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities.

John P O'Rourke1, Scott A Ness.   

Abstract

The c-Myb transcription factor regulates the proliferation and differentiation of hematopoietic cells, and activated alleles of c-myb induce leukemias and lymphomas in animals. Relatively minor changes in the structure of c-Myb protein change the genes that it regulates and can unleash its latent transforming activities. Here, quantitative assays were used to analyze the alternative splicing of human c-myb transcripts. We identified an array of variant transcripts, expressed in highly regulated, lineage-specific patterns, that were formed through the use of alternate exons 8A, 9A, 9B, 10A, 13A, and 14A. Expression levels of the different splice variant transcripts were regulated independently of one another during human hematopoietic cell differentiation, and the alternative splicing of c-myb mRNAs was increased in primary leukemia samples. The alternatively spliced c-myb transcripts were associated with polysomes and encoded a series of c-Myb proteins with identical DNA binding domains but unique C-terminal domains. In several types of assays, the variant c-Myb proteins exhibited quantitative and qualitative differences in transcriptional activities and specificities. The results suggest that the human c-myb gene encodes a family of related proteins with different transcriptional activities. Enhanced alternative splicing may be a mechanism for unmasking the transforming activity of c-myb in human leukemias.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18195038      PMCID: PMC2268396          DOI: 10.1128/MCB.01870-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene.

Authors:  Claudia Ghigna; Silvia Giordano; Haihong Shen; Federica Benvenuto; Fabio Castiglioni; Paolo Maria Comoglio; Michael R Green; Silvano Riva; Giuseppe Biamonti
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

2.  Oncogenic mutations cause dramatic, qualitative changes in the transcriptional activity of c-Myb.

Authors:  F Liu; W Lei; J P O'Rourke; S A Ness
Journal:  Oncogene       Date:  2006-02-02       Impact factor: 9.867

3.  Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter.

Authors:  T Bellon; D Perrotti; B Calabretta
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

4.  Transcriptional profiling of human hematopoiesis during in vitro lineage-specific differentiation.

Authors:  Martina Komor; Saskia Güller; Claudia D Baldus; Sven de Vos; Dieter Hoelzer; Oliver G Ottmann; Wolf-K Hofmann
Journal:  Stem Cells       Date:  2005-06-13       Impact factor: 6.277

5.  B-myb is required for inner cell mass formation at an early stage of development.

Authors:  Y Tanaka; N P Patestos; T Maekawa; S Ishii
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

Review 6.  The connection between splicing and cancer.

Authors:  Anabella Srebrow; Alberto R Kornblihtt
Journal:  J Cell Sci       Date:  2006-07-01       Impact factor: 5.285

7.  Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1.

Authors:  Wanli Lei; Fan Liu; Scott A Ness
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

Review 8.  Aberrant and alternative splicing in cancer.

Authors:  Julian P Venables
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

Review 9.  Myb binding proteins: regulators and cohorts in transformation.

Authors:  S A Ness
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

10.  Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism.

Authors:  J D Leverson; S A Ness
Journal:  Mol Cell       Date:  1998-01       Impact factor: 17.970

View more
  26 in total

Review 1.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

2.  Editorial: Targeting MYB Oncogene Expression in Adenoid Cystic Carcinoma.

Authors:  Scott A Ness
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 13.506

3.  p89c-Myb is not required for fetal or adult hematopoiesis.

Authors:  Stacey J Baker; Atul Kumar; E Premkumar Reddy
Journal:  Genesis       Date:  2010-05       Impact factor: 2.487

4.  miR-150 Regulates Memory CD8 T Cell Differentiation via c-Myb.

Authors:  Zeyu Chen; Erietta Stelekati; Makoto Kurachi; Sixiang Yu; Zhangying Cai; Sasikanth Manne; Omar Khan; Xiaolu Yang; E John Wherry
Journal:  Cell Rep       Date:  2017-09-12       Impact factor: 9.423

5.  Metnase mediates chromosome decatenation in acute leukemia cells.

Authors:  Justin Wray; Elizabeth A Williamson; Sheema Sheema; Suk-Hee Lee; Edward Libby; Cheryl L Willman; Jac A Nickoloff; Robert Hromas
Journal:  Blood       Date:  2009-05-20       Impact factor: 22.113

6.  c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.

Authors:  Shenghao Jin; Huiwu Zhao; Yan Yi; Yuji Nakata; Anna Kalota; Alan M Gewirtz
Journal:  J Clin Invest       Date:  2010-01-19       Impact factor: 14.808

7.  GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas.

Authors:  Beverly W Baron; John Anastasi; Juraj Bies; Poluru L Reddy; Loren Joseph; Michael J Thirman; Kristen Wroblewski; Linda Wolff; Joseph M Baron
Journal:  Blood Cells Mol Dis       Date:  2013-07-30       Impact factor: 3.039

8.  Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.

Authors:  Feng Fang; Michael A Rycyzyn; Charles V Clevenger
Journal:  Endocrinology       Date:  2008-11-26       Impact factor: 4.736

9.  Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.

Authors:  Kathryn J Brayer; Candace A Frerich; Huining Kang; Scott A Ness
Journal:  Cancer Discov       Date:  2015-12-02       Impact factor: 39.397

Review 10.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.